Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls.

Ruddy KJ, Gelber S, Ginsburg ES, Schapira L, Abusief ME, Meyer ME, Partridge AH.

Menopause. 2011 Jan;18(1):105-8.

PMID:
21243735
2.

Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls.

Palmer JL, Trotter T, Joy AA, Carlson LE.

J Cancer Surviv. 2008 Dec;2(4):275-82. doi: 10.1007/s11764-008-0070-1. Epub 2008 Oct 16.

PMID:
18923905
3.

Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.

Parton M, Smith IE.

J Clin Oncol. 2008 Feb 10;26(5):745-52. doi: 10.1200/JCO.2007.14.3016. Review. No abstract available.

PMID:
18258982
4.

Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.

Cohen I, Figer A, Tepper R, Shapira J, Altaras MM, Yigael D, Beyth Y.

Gynecol Oncol. 1999 Feb;72(2):202-7.

PMID:
10021302
5.

Adjuvant endocrine therapy for premenopausal women with early breast cancer.

Dellapasqua S, Colleoni M, Gelber RD, Goldhirsch A.

J Clin Oncol. 2005 Mar 10;23(8):1736-50. Review. No abstract available.

PMID:
15755982
6.

Ovarian suppression for breast cancer: an effective treatment in search of a home.

Krop IE, Winer EP.

J Clin Oncol. 2005 Sep 1;23(25):5869-72. Epub 2005 Aug 8. No abstract available.

7.

Selection of optimal adjuvant endocrine therapy for early-stage breast cancer.

Al-Hajj A, O'Regan R.

Curr Treat Options Oncol. 2006 Mar;7(2):153-65. Review.

PMID:
16455026
8.

Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer--self-rated physiological effects and symptoms.

Nystedt M, Berglund G, Bolund C, Brandberg Y, Fornander T, Rutqvist LE.

Acta Oncol. 2000;39(8):959-68.

PMID:
11207003
9.

Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.

Partridge AH, Ruddy KJ, Gelber S, Schapira L, Abusief M, Meyer M, Ginsburg E.

Fertil Steril. 2010 Jul;94(2):638-44. doi: 10.1016/j.fertnstert.2009.03.045. Epub 2009 May 5.

PMID:
19409543
10.
11.

[Hormone therapy in breast cancer: the end of tamoxifen?].

Delozier T.

Bull Cancer. 2005 Feb;92(2):142-50. Review. French.

PMID:
15749643
12.

Adjuvant endocrine therapy in premenopausal women with breast cancer.

González Martín A, de la Cruz S, Márquez R.

Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:43-7. doi: 10.1007/s10549-010-1045-2. Epub 2010 Aug 14. No abstract available.

PMID:
20711666
13.

Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study.

Nystedt M, Berglund G, Bolund C, Fornander T, Rutqvist LE.

J Clin Oncol. 2003 May 1;21(9):1836-44.

PMID:
12721261
14.
15.

Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.

Ilanchezhian S, Thangaraju M, Sachdanandam P.

Cancer Biochem Biophys. 1995 Nov;15(2):83-90.

PMID:
8590439
16.

Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.

Sverrisdóttir A, Fornander T, Jacobsson H, von Schoultz E, Rutqvist LE.

J Clin Oncol. 2004 Sep 15;22(18):3694-9.

17.

Adjuvant endocrine therapy for premenopausal women with early breast cancer.

Bao T, Davidson NE.

Breast Cancer Res. 2007;9(6):115. doi: 10.1186/bcr1830.

18.

Menopausal-type symptoms in young breast cancer survivors.

Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH.

Ann Oncol. 2006 Dec;17(12):1777-82. Epub 2006 Sep 13.

19.

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.

Alkner S, Bendahl PO, Fernö M, Nordenskjöld B, Rydén L; South Swedish and South-East Swedish Breast Cancer Groups.

Eur J Cancer. 2009 Sep;45(14):2496-502. doi: 10.1016/j.ejca.2009.05.022. Epub 2009 Jun 15.

PMID:
19535242
20.

The role of ovarian ablation in the management of breast cancer.

Wirk B.

Breast J. 2005 Nov-Dec;11(6):416-24. Review.

PMID:
16297086
Items per page

Supplemental Content

Write to the Help Desk